SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (115876)10/31/2000 5:43:13 PM
From: 2MAR$  Read Replies (1) of 120523
 
Bristol-Myers says US OKs new version of HIV drug

WASHINGTON, Oct 31 (Reuters) - Bristol-Myers Squibb Co.
<BMY.N> said on Tuesday U.S. regulators approved a new version
of its anti-HIV drug Videx that can be taken daily as a single
pill and has fewer side effects than the older formula.
The Food and Drug Administration cleared the new formula,
known as Videx EC, company spokesman John Kouten said. The
older formulation required two pills once per day.
Videx is approved for use as part of a cocktail of drugs to
fight HIV, the virus that causes AIDS.
REUTERS
*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News